Analyst Reco. Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Real-time Estimate Cboe BZX Other stock markets 03:33:35 2024-07-12 pm EDT			5-day change	1st Jan Change
57.5 ^USD	-1.94%		+12.78%	+210.69%

Jul. 01	Viking Therapeutics, Inc.(NasdaqCM:VKTX) added to Russell 1000 Dynamic Index	CI
Jul. 01	Viking Therapeutics, Inc.(NasdaqCM:VKTX) added to Russell Midcap Growth Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Initiates Viking Therapeutics at Overweight With $105 Price Target	Jun. 27	MT
Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform	May. 17	MT
Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing	May. 06	MT
Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing	May. 03	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $138 From $116, Maintains Outperform Rating	Mar. 27	MT
Stifel Adjusts Viking Therapeutics Price Target to $95 From $80, Maintains Buy Rating	Mar. 26	MT
BTIG Raises Price Target on Viking Therapeutics to $100 From $86, Keeps Buy Rating	Mar. 15	MT
Jefferies Starts Viking Therapeutics With Buy Rating, $110 Price Target	Mar. 07	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $116 From $46, Maintains Outperform Rating	Feb. 28	MT
HC Wainwright Raises Price Target on Viking Therapeutics to $90 From $33, Keeps Buy Rating	Feb. 27	MT
Stifel Adjusts Price Target on Viking Therapeutics to $35 From $30, Maintains Buy Rating	Feb. 14	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $46 From $40, Maintains Outperform Rating	Feb. 08	MT
Raymond James Adjusts Viking Therapeutics Price Target to $37 From $35, Maintains Outperform Rating	23-05-17	MT
Stifel Adjusts Viking Therapeutics' Price Target to $30 From $25, Keeps Buy Rating	23-05-16	MT
BTIG Adjusts Viking Therapeutics' Price Target to $36 From $31, Keeps Buy Rating	23-05-16	MT
Roth MKM Adjusts Price Target on Viking Therapeutics to $24 From $19, Maintains Buy Rating	23-05-03	MT
HC Wainwright Adjusts Price Target on Viking Therapeutics to $33 From $21, Maintains Buy Rating	23-04-27	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $35 From $30, Maintains Outperform Rating	23-04-25	MT
BTIG Research Adjusts Viking Therapeutics Price Target to $31 From $20, Maintains Buy Rating	23-03-29	MT
Raymond James Adjusts Viking Therapeutics Price Target to $35 From $12, Maintains Outperform Rating	23-03-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Analyst Reco.

Filters